President Donald Trump directed his administration Monday to use its trade, regulatory and enforcement powers to establish a “most-favored nation” [...] …
Category: General
A California think tank, and an influential drug industry trade group that funds it, are raising concerns that President Donald [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key national hospital advocacy group recently urged the Trump administration to modify the retrospective payment process under the Inflation [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A new bipartisan U.S. Senate proposal, backed by a key lawmaker involved in 340B policy, aims to lower the cost [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
News Alert
Trump’s FY 2026 Budget Blueprint Includes $33 Billion in HHS Cuts, No Details on 340B Plans
President Donald Trump’s Fiscal Year 2026 budget blueprint released Friday calls for major cuts and shakeups at the U.S. Department [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A major national 340B provider advocacy group this week cautioned that proposed 340B reforms stemming from a high-profile GOP U.S. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two major drug manufacturers are loosening their 340B contract pharmacy restrictions for states that have passed contract pharmacy access laws [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two influential players in the 340B world have recently taken on key positions at retail pharmacy giant Walgreens, one of [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Japanese pharmaceutical giant and Massachusetts biotechnology company recently announced changes to their respective 340B contract pharmacy restrictions. Tokyo-based Takeda [...] …